NVST Stock Chart & Stats
$371.00
$0.00(0.00%)
―
--
Day’s Range― - ―
52-Week Range$351.13 - $400.00
Previous CloseN/A
VolumeN/A
Average Volume (3M)0.00
Market Cap
$74.91B
Enterprise Value$4.80K
Total Cash (Recent Filing)$1.08B
Total Debt (Recent Filing)$1.59B
Price to Earnings (P/E)62.7
Beta-0.06
Next Earnings
Aug 05, 2026EPS Estimate
5.88Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)0.42
Shares OutstandingN/A
10 Day Avg. Volume0
30 Day Avg. Volume0
Financial Highlights & Ratios
PEG Ratio-0.74
Price to Book (P/B)1.17
Price to Sales (P/S)1.34
P/FCF Ratio15.83
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price Target
$523.32Price Target Upside― Downside
Rating ConsensusModerate Buy
Number of Analyst Covering11
EPS Forecast (FY)N/A
Revenue Forecast (FY)N/A
Bulls Say, Bears Say
Bulls Say
High Gross MarginsSustained ~55% gross margins reflect a consumables- and technology-heavy portfolio with pricing power and scale benefits. High gross margins create durable profit cushions against cost inflation, enabling investment in product R&D, SG&A leverage and protecting operating margins over the medium term.
Strong Free Cash FlowConsistent FCF generation (TTM $220M) and management's ~100% conversion target provide durable flexibility for buybacks, tuck-in M&A and debt repayment. Reliable cash conversion reduces reliance on external financing and supports capital allocation even if revenue growth moderates.
Product & Portfolio StrengthOutperformance across Specialty and Equipment, plus differentiated launches (Nobel S, DEXIS AI, Spark) and accretive tuck-ins (Versah), strengthen competitive moats. A broad installed base and innovation pipeline support repeat consumable sales and cross-sell, enhancing durable revenue mix and market share.
Bears Say
Thin Net Margins & Low ROEDespite strong gross margins, net profitability and ROE remain low and have swung negative in recent years. Thin net margins limit retained earnings and capital returns, making sustained reinvestment and consistent shareholder returns vulnerable if top-line or margin expansion stalls.
China VBP & Implant DestockingVolume-based procurement (VBP) timing and channel destocking in China present a structural revenue and margin risk for implants. Such procurement shifts can compress channels, delay recognition of demand recovery and require longer-term commercial adjustments to pricing, distribution and service models.
Tariffs, CapEx And Debt LoadElevated tariff costs (~$11M) and near-term CapEx drove Q1 negative FCF, while meaningful total debt (~$1.59B) constrains flexibility. If tariffs persist or capex runs above plan, leverage and cash cushions could be eroded, pressuring capital allocation and margin resilience over the medium term.
NVST FAQ
What was Envista Holdings’s price range in the past 12 months?
Envista Holdings lowest stock price was $351.13 and its highest was $400.00 in the past 12 months.
What is Envista Holdings’s market cap?
Envista Holdings’s market cap is $74.91B.
When is Envista Holdings’s upcoming earnings report date?
Envista Holdings’s upcoming earnings report date is Aug 05, 2026 which is in 10 days.
How were Envista Holdings’s earnings last quarter?
Envista Holdings released its earnings results on May 06, 2026. The company reported $6.303 earnings per share for the quarter, beating the consensus estimate of $5.463 by $0.84.
Is Envista Holdings overvalued?
According to Wall Street analysts Envista Holdings’s price is currently Undervalued.
Does Envista Holdings pay dividends?
Envista Holdings does not currently pay dividends.
What is Envista Holdings’s EPS estimate?
Envista Holdings’s EPS estimate is 5.88.
How many shares outstanding does Envista Holdings have?
Currently, no data Available
What happened to Envista Holdings’s price movement after its last earnings report?
Envista Holdings reported an EPS of $6.303 in its last earnings report, beating expectations of $5.463. Following the earnings report the stock price went same 0%.
Which hedge fund is a major shareholder of Envista Holdings?
Currently, no hedge funds are holding shares in MX:NVST
What is the TipRanks Smart Score and how is it calculated?
Smart Score combines eight research factors - such as analyst recommendations, hedge fund trends, and technical indicators - to measure a stock’s outlook. These signals are unified into a single score that reflects bullish or bearish momentum. See detailed methodology
Envista Holdings Stock Smart Score
Neutral
1
2
3
4
5
6
7
8
9
10
Analyst Consensus
Moderate Buy
Average Price Target:
$523.32 (― Downside)
$523.32 (― Downside)
Blogger Sentiment
Bullish
MX:NVST Sentiment 100%
Sector Average 65%
Sector Average 65%
News Sentiment
Neutral
Bullish news 50%
Bearish news 50%
Bearish news 50%
Technicals
SMA
Positive
20 days / 200 days
Momentum
26.12%
12-Months-Change
Fundamentals
Return on Equity
―
Trailing 12-Months
Asset Growth
2.04%
Trailing 12-Months
Company Description
Envista Holdings
Envista Holdings Corporation is an enterprise dedicated to the development and distribution of a comprehensive range of dental solutions. These offerings are crucial for the identification, therapeutic intervention, and preventative care of diverse oral health issues, specifically addressing the teeth, gingiva (gums), and their supporting bone structures. The company's principal location is in Brea, California, and it maintains a workforce comprising 12,800 full-time personnel. The firm organizes its business activities into two main divisions: "Specialty Products & Technologies" and "Equipment & Consumables." The Specialty Products & Technologies division concentrates on the creation, fabrication, and promotion of sophisticated dental implant systems, advanced prosthetic devices, and their associated digital treatment software and technological advancements. This segment also provides orthodontic remedies, including bracket systems, clear aligners, and various items for dental laboratories. Conversely, the Equipment & Consumables division is responsible for conceptualizing, producing, and bringing to market a wide array of dental apparatus and vital supplies intended for professional dental clinics. This extensive catalog includes digital imaging instruments, specialized software, and visual or magnification systems; patient treatment units and other essential fixtures for dental practices; complete endodontic kits along with their complementary consumable items; materials and tools for restorative dentistry; rotary cutting tools (burs); impression-making compounds; adhesive agents and dental cements; and products designed for infection control.
NVST Stock 12 Month Forecast
Average Price Target
$523.32